Skip to content

Addiction research published in 2021

Page 3 of 4: studies 41 to 60 of 61, newest first. Back to the addiction overview

Studies

Widespread Cortical Thickness Reductions Following Non-medical Use of Ketamine: a Structural MRI Study of Individuals with Ketamine Dependence

medRxiv Preprint Server February 21, 2021 Jinsong Tang, Qiuxia Wu, Chang Qi et al. preprint

Background A version of ketamine, called Esketamine has been approved for treatment-resistant depression (TRD). Ketamine (“K powder”), a “dissociative” anesthetic agent, however, has been used non-medically alone or with other illicit substances. Our previous studies showed a link between non-medical ketamine use and brain structural and functional alterations. We found dorsal prefrontal gray...

DOI: 10.1101/2021.02.21.21252178 (opens in new tab) Full text (opens in new tab) Ketamine abuse Recreational ketamine use Illicit ketamine Ketamine dependence +11

First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder.

Journal of Psychopharmacology February 18, 2021 Ben Sessa, Laurie Higbed, Steve O’Brien et al. 123 citations

Background: 3,4-methylenedioxymethamphetamine (MDMA) therapy has qualities that make it potentially well suited for patients with addictions, but this has never been explored in a research study. We present data from the Bristol Imperial MDMA in Alcoholism (BIMA) study. This is the first MDMA addiction study, an open-label safety and tolerability proof-of-concept study investigating the...

How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence

Anesthesia & Analgesia February 17, 2021 Peter G. Brindley 49 citations

It is tough to write about psychedelics without a few gratuitous puns. Regardless, Michael Pollan’s “How to Change Your Mind” is definitely “mind expanding” and deserves my “highest” recommendation. Published in 2019, this book comprehensively and presciently covers a topic of increasing interest: whether psychedelic agents can revolutionize mental health. Pollan is not a Medical Doctor but is...

DOI: 10.1213/ane.0000000000005349 (opens in new tab) Psilocybin Counterculture Consciousness Psychic +4

Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach

Frontiers in Psychiatry February 9, 2021 Valeria Catalani, Davide Arillotta, John Corkery et al. 38 citations

COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. The aims of the current research were to use a web crawler, NPSfinder®, to identify and categorize emerging NPS discussed on a range of drug...

DOI: 10.3389/fpsyt.2020.632405 (opens in new tab) Addiction Social media Pandemic Illicit drug +4

Out of our heads: Addiction and psychiatric externalism.

Behavioural Brain Research February 1, 2021 Shane N Glackin, Tom Roberts, Joel Krueger 28 citations

In addiction, apparently causally significant phenomena occur at a huge number of levels; addiction is affected by biomedical, neurological, pharmacological, clinical, social, and politico-legal factors, among many others. In such a complex, multifaceted field of inquiry, it seems very unlikely that all the many layers of explanation will prove amenable to any simple or straightforward,...

Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial.

Journal of Psychopharmacology February 1, 2021 Rebecca L Rothberg, Nour Azhari, Nancy A Haug et al. 95 citations

Sub-anesthetic ketamine administration may be helpful for substance use disorders. Converging evidence suggests that the efficacy of ketamine for certain conditions may implicate a subset of its psychoactive effects. The aim of this analysis is to evaluate whether the mystical-type effects of ketamine are critical for clinical efficacy in alcohol-dependent individuals. In this secondary...

Use and abuse of dissociative and psychedelic drugs in adolescence

Pharmacology, Biochemistry, and Behavior January 27, 2021 M.l. Shawn Bates, Keith A Trujillo 57 citations

Adolescence is a period of profound developmental changes, which run the gamut from behavioral and neural to physiological and hormonal. It is also a time at which there is an increased propensity to engage in risk-taking and impulsive behaviors like drug use. This review examines the human and preclinical literature on adolescent drug use and its consequences, with a focus on dissociatives...

Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine

Therapeutic Advances in Psychopharmacology 2021 David M. O’shaughnessy, Ilana Berlowitz, Robin Rodd et al.

Aims: The therapeutic use of psychedelics is regaining scientific momentum, but similarly psychoactive ethnobotanical substances have a long history of medical (and other) uses in indigenous contexts. Here we aimed to evaluate patient outcomes in a residential addiction treatment center that employs a novel combination of Western and traditional Amazonian methods. Methods: The study was...

Cannabis Use and Psychosis – Modern Views on the Problem. Narrative Synthesis

Medicina 2021 A. J. Kolgashkin, П. Н. Николаев, E. J. Tetenova et al. 1 citation

Cannabis continues to be the most widely used drug worldwide. Recently, there has been two trends in the field: a liberalization of cannabis-related legislation in a number of countries, as well as an increase in the content of the psychoactive component in cannabis plant – tetrahydrocannabinol. The review covers a topic that has been little studied in Russian addiction science – cannabis use...

Self-reported PTSD is associated with increased use of MDMA in adolescents with substance use disorders

European Journal of Psychotraumatology 2021 Lukas A Basedow, Sören Kuitunen-Paul, Melina Wiedmann et al. 15 citations

ABSTRACT Background: Adolescent patients with a substance use disorder (SUD) often fulfil the criteria for a co-occurring post-traumatic stress disorder (PTSD). However, it is not clear if these dual-diagnosed adolescents present with unique levels of substance use and how their substance use relates to PTSD symptom clusters. Objective: To investigate substance use in adolescents with...

The Declaration of Interdependence! Feminism, Grounding and Enactivism.

Human Studies 2021 Anya Daly 7 citations

This paper explores the issue whether feminism needs a metaphysical grounding, and if so, what form that might take to effectively take account of and support the socio-political demands of feminism; addressing these demands I further propose will also contribute to the resolution of other social concerns. Social constructionism is regularly invoked by feminists and other political activists...

The good, the bad, and the intoxicated

2021 Natasha Leigh Mason

Cannabis is the most commonly used illicit drug and is known to alter state of consciousness and impair neurocognitive function. However, the mechanisms underlying these effects have yet to be fully elucidated. Rodent studies suggest that 9-tetrahydrocannabinol (THC) activates dopaminergic neurons in the limbic system, subsequently enhancing dopamine, which is implicated in the rewarding...

Traditional Use of Banisteriopsis caapi Alone and Its Application in a Context of Drug Addiction Therapy.

Journal of Psychoactive Drugs 2021 Matteo Politi, Fabio Friso, Gary Saucedo et al. 18 citations

Takiwasi is a therapeutic community for the treatment of Substance Use Disorders (SUDs) that combines traditional Amazonian medicine (TAM) with modern psychotherapy. One of the plant medicines from TAM used in this protocol is purgahuasca. It is a decoction of the vine Banisteriopsis caapi alone, whose use is traditional among the Awajún and other ethnic groups in Peru. The research began with...

Using Drugs to Treat Drug Dependence: Exploring the Use of MDMA-Assisted Psychotherapy for Individuals with PTSD and Concurrent Substance Use

Psychology and Behavioral Sciences 2021 Brenda Tichler

The importance of treating concurrent Post-Traumatic Stress Disorder (PTSD) and substance use with psychedelics is a controversial topic, hampered in part by a lack of empirical evidence and rigidity of substance scheduling. Traditional treatments for concurrent PTSD and substance use concerns are compartmentalized, with clinicians focusing on one condition over the other. In addition,...

Psychosis induced by abuse of ayahuasca: a case report.

Revista Colombiana de psiquiatria 2021 Raul Felipe Palma-álvarez, Lara Grau-López, Elena Ros-Cucurull et al. 12 citations

Ayahuasca is a psychotropic infusion prepared by boiling the bark of Amazonian plants and has many psychopharmacological effects not fully understood. Some of those effects are used as treatment for different diseases. However, the side effects of ayahuasca, including ayahuasca-induced psychosis, are an important issue. Here we report the case of a patient who had a psychotic episode after...

5-HT2A and 5-HT2C receptors as potential targets for the treatment of nicotine use and dependence.

Progress in Brain Research 2021 Guy A. Higgins, Edward M. Sellers 10 citations

Nicotine use and dependence, typically achieved through cigarette smoking, but increasingly through vape products, is the leading cause of preventable death today. Despite a recognition that many current smokers would like to quit, the success rate at doing so is low and indicative of the persistent nature of nicotine dependence and the high urge to relapse. There are currently three main forms...

Engineering Safer Psychedelics for Treating Addiction.

Neuroscience Insights 2021 Jamie Peters, David E. Olson 38 citations

Addiction is best described as a disorder of maladaptive neuroplasticity involving the simultaneous strengthening of reward circuitry that drives compulsive drug seeking and weakening of circuits involved in executive control over harmful behaviors. Psychedelics have shown great promise for treating addiction, with many people attributing their therapeutic effects to insights gained while under...

"This Is Something That Changed My Life": A Qualitative Study of Patients' Experiences in a Clinical Trial of Ketamine Treatment for Alcohol Use Disorders.

Frontiers in Psychiatry 2021 Özden Merve Mollaahmetoğlu, Johanna Keeler, Katherine J Ashbullby et al. 62 citations

Background: The therapeutic benefits of ketamine have been demonstrated for a variety of psychiatric disorders. However, the role of ketamine induced psychoactive experiences in mediating the therapeutic effects is unclear. Despite the growing quantitative research on the efficacy of ketamine treatment, very few studies examined participant experiences of ketamine infusions in a treatment...